Sep 2021
GI CONNECT has summarised the highlights of the recent ASCO GI 2018 meeting for you.
Cancers of the lower GI tract by Priv.-Doz. Dr. Thomas Winder, Academic Teaching Hospital Feldkirch, Austria, Swiss Tumor Molecular Institute and University Zurich, Switzerland
Dr Thomas Winder is board certified for haematology and medical oncology. Since January 2020 he has been Head of the Department for Haematology and Oncology at the University Teaching Hospital Feldkirch, Austria. In addition, since 2017 he has been President of the Swiss Tumor Molecular Institute in Zürich Switzerland. Dr Winder’s research focuses on molecular markers to individualize medical treatment of cancer patients. He achieved his expertise in internationally renowned laboratories at University of Southern California, Norris Comprehensive Cancer Center, Los Angeles and University Hospital Zürich, Switzerland. His research activity has been honoured by several national and international awards and high impact publications.
Duration
5 MIN
Downloadable resources
Yes
Download the slides
Language(s)
GI CONNECT update from ASCO GI 2018
Episode 1: Cancers of the lower GI tract Current Episode
Animated Video
Expert insights into personalised treatment strategies in BRAF-mutated NSCLC
Downloadable 
6 MIN
May 2025 
Animated Video
Optimising treatment strategies and AE management
Downloadable
MIN
May 2025 
Podcast
Navigating common treatment scenarios in HER2-mutant non-small cell lung cancer
Downloadable
18 MIN
Apr 2025
Publication
Downloadable
20 MIN
Apr 2025
Animated Video
An overview of the EMERALD subgroup analyses
Downloadable
8 MIN
Apr 2025 
Podcast
A medical oncologist and a pathologist share their perspectives on best practices in identifying HER2-directed NSCLC
Downloadable
20 MIN
Apr 2025
